Correlation Between Sartorius Stedim and Mauna Kea

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Mauna Kea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Mauna Kea into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Mauna Kea Technologies, you can compare the effects of market volatilities on Sartorius Stedim and Mauna Kea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Mauna Kea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Mauna Kea.

Diversification Opportunities for Sartorius Stedim and Mauna Kea

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Sartorius and Mauna is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Mauna Kea Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mauna Kea Technologies and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Mauna Kea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mauna Kea Technologies has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Mauna Kea go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Mauna Kea

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.82 times more return on investment than Mauna Kea. However, Sartorius Stedim Biotech is 1.22 times less risky than Mauna Kea. It trades about 0.0 of its potential returns per unit of risk. Mauna Kea Technologies is currently generating about -0.08 per unit of risk. If you would invest  20,146  in Sartorius Stedim Biotech on August 27, 2024 and sell it today you would lose (2,646) from holding Sartorius Stedim Biotech or give up 13.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Mauna Kea Technologies

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Mauna Kea Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mauna Kea Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Sartorius Stedim and Mauna Kea Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Mauna Kea

The main advantage of trading using opposite Sartorius Stedim and Mauna Kea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Mauna Kea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mauna Kea will offset losses from the drop in Mauna Kea's long position.
The idea behind Sartorius Stedim Biotech and Mauna Kea Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Directory
Find actively traded commodities issued by global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments